Skip to content
Awesome – Lifestyle
Author:
Cardinal Infrastructure Group Inc.
Cardinal Infrastructure Group Announces Proposed Public Offering of Common Stock
June 22, 2026
Cardinal Infrastructure Group Announces Acquisition of Piedmont Pipe Construction
June 2, 2026
U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
May 28, 2026
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
May 22, 2026
Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults
May 22, 2026
Cardinal Infrastructure Group Strengthens Operational Leadership Across its Footprint
May 21, 2026
Cardinal Infrastructure Group to Participate in Upcoming Investor Conferences
May 19, 2026
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®
May 5, 2026
Cardinal Infrastructure Group Schedules First Quarter 2026 Earnings Conference Call
April 29, 2026
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
April 29, 2026
1
2
Next Page
→